Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice.
Saved in:
| Title: | Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice. |
|---|---|
| Authors: | Shekhar TM; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia., Burvenich IJG; Tumour Targeting Laboratory, Ludwig Institute for Cancer Research and Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Harris MA; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia., Rigopoulos A; Tumour Targeting Laboratory, Ludwig Institute for Cancer Research and Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Zanker D; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia., Spurling A; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia., Parker BS; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia., Walkley CR; St. Vincent's Institute, Fitzroy, Victoria, 3065, Australia.; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, 3065, Australia.; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, 3000, Australia., Scott AM; Tumour Targeting Laboratory, Ludwig Institute for Cancer Research and Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia.; Departments of Medical Oncology and Molecular Imaging & Therapy, Austin Health, Heidelberg, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia., Hawkins CJ; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia. c.hawkins@latrobe.edu.au. |
| Source: | BMC cancer [BMC Cancer] 2019 Sep 14; Vol. 19 (1), pp. 924. Date of Electronic Publication: 2019 Sep 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31521127 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shekhar+TM%22">Shekhar TM</searchLink>; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia.<br /><searchLink fieldCode="AU" term="%22Burvenich+IJG%22">Burvenich IJG</searchLink>; Tumour Targeting Laboratory, Ludwig Institute for Cancer Research and Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Harris+MA%22">Harris MA</searchLink>; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia.<br /><searchLink fieldCode="AU" term="%22Rigopoulos+A%22">Rigopoulos A</searchLink>; Tumour Targeting Laboratory, Ludwig Institute for Cancer Research and Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Zanker+D%22">Zanker D</searchLink>; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia.<br /><searchLink fieldCode="AU" term="%22Spurling+A%22">Spurling A</searchLink>; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia.<br /><searchLink fieldCode="AU" term="%22Parker+BS%22">Parker BS</searchLink>; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia.<br /><searchLink fieldCode="AU" term="%22Walkley+CR%22">Walkley CR</searchLink>; St. Vincent's Institute, Fitzroy, Victoria, 3065, Australia.; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, 3065, Australia.; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+AM%22">Scott AM</searchLink>; Tumour Targeting Laboratory, Ludwig Institute for Cancer Research and Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Australia.; Departments of Medical Oncology and Molecular Imaging & Therapy, Austin Health, Heidelberg, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Hawkins+CJ%22">Hawkins CJ</searchLink>; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, 3086, Australia. c.hawkins@latrobe.edu.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2019 Sep 14; Vol. 19 (1), pp. 924. <i>Date of Electronic Publication: </i>2019 Sep 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31521127 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-019-6103-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 924 Titles: – TitleFull: Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shekhar TM – PersonEntity: Name: NameFull: Burvenich IJG – PersonEntity: Name: NameFull: Harris MA – PersonEntity: Name: NameFull: Rigopoulos A – PersonEntity: Name: NameFull: Zanker D – PersonEntity: Name: NameFull: Spurling A – PersonEntity: Name: NameFull: Parker BS – PersonEntity: Name: NameFull: Walkley CR – PersonEntity: Name: NameFull: Scott AM – PersonEntity: Name: NameFull: Hawkins CJ IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 09 Text: 2019 Sep 14 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 19 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |